| 6.13 -0.01 (-0.16%) | 10-28 14:34 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 7.94 | 1-year : | 8.54 |
| Resists | First : | 6.8 | Second : | 7.32 |
| Pivot price | 6.27  |
|||
| Supports | First : | 5.96 | Second : | 4.96 |
| MAs | MA(5) : | 6.19 |
MA(20) : | 6.41 |
| MA(100) : | 8.71 |
MA(250) : | 7.31 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 21.5 |
D(3) : | 21.1 |
| RSI | RSI(14): 42.3 |
|||
| 52-week | High : | 15.84 | Low : | 3.99 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ LFMD ] has closed above bottom band by 28.2%. Bollinger Bands are 76% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 44 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 6.43 - 6.46 | 6.46 - 6.5 |
| Low: | 6.05 - 6.09 | 6.09 - 6.12 |
| Close: | 6.08 - 6.15 | 6.15 - 6.2 |
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
Mon, 27 Oct 2025
LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
Mon, 27 Oct 2025
Portnoy Law Firm Announces Class Action on Behalf of LifeMD, Inc. Investors - GlobeNewswire
Mon, 27 Oct 2025
HIMS vs. LFMD: Which Telehealth Stock Is the Better Investment Now? - TradingView
Mon, 27 Oct 2025
Class Action Filed Against LifeMD, Inc. (LFMD) Seeking Recovery for Investors - Contact The Gross Law Firm - PR Newswire
Sun, 26 Oct 2025
LFMD DEADLINE TOMORROW: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages LifeMD, Inc. Investors ... - Bluefield Daily Telegraph
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Pharmaceuticals
|
|
| Shares Out | 47 (M) |
| Shares Float | 38 (M) |
| Held by Insiders | 16 (%) |
| Held by Institutions | 53.6 (%) |
| Shares Short | 4,170 (K) |
| Shares Short P.Month | 4,970 (K) |
| EPS | -0.21 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.04 |
| Profit Margin | -2.5 % |
| Operating Margin | -1.5 % |
| Return on Assets (ttm) | -1.9 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 22.7 % |
| Gross Profit (p.s.) | 4.53 |
| Sales Per Share | 5.17 |
| EBITDA (p.s.) | -0.01 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 19 (M) |
| Levered Free Cash Flow | 8 (M) |
| PE Ratio | -30.68 |
| PEG Ratio | 0 |
| Price to Book value | -153.38 |
| Price to Sales | 1.18 |
| Price to Cash Flow | 14.93 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|